HPV Vaccine Launches Nationwide in India
Reaction from the field
The recent launch of the HPV vaccination program in India marks a significant step towards combating cervical cancer, which is the second-most prevalent form of cancer among Indian women. With HPV being the leading cause of this disease, the introduction of the vaccine is poised to prevent nearly 90% of cervical cancer cases, according to health experts.
The vaccination program, which commenced on February 28, 2026, aims to vaccinate 14-year-old girls across the country. This initiative is particularly crucial as India accounts for over 65% of the regional burden of cervical cancer, highlighting the urgent need for effective preventive measures.
Administered free of cost at government health facilities, the HPV vaccine is available in three approved forms: Cervarix®, Gardasil®, and Gardasil-9®. The ongoing campaign utilizes the single-dose Gardasil-4 vaccine, which has been recognized for its cost-effectiveness, being viable at a threshold of 30% of GDP per capita.
Dr. Chandini, a prominent health official, emphasized the safety and efficacy of the HPV vaccine, stating, “The HPV vaccine is safe and can prevent nearly 90 percent of cervical cancer, which is the second most common cancer among women in India.” This statement underscores the potential impact of the vaccination program on public health.
Vaccination is voluntary and requires parental consent, ensuring that families have a say in their children’s healthcare decisions. This approach aims to foster community trust and encourage participation in the vaccination program.
Historically, HPV vaccines were introduced in India in 2008, with state governments in Sikkim and Punjab launching their own programs as early as 2016. The current nationwide initiative builds on these earlier efforts, expanding access and awareness across the country.
The vaccination campaign is expected to last for 90 days, during which health officials will work diligently to reach as many eligible girls as possible. The program is not only a public health initiative but also a critical move towards strengthening preventive healthcare in India.
As the campaign unfolds, the focus will be on monitoring its effectiveness and the overall impact on cervical cancer rates in the coming years. Details remain unconfirmed regarding the long-term outcomes of this initiative, but the potential for significant health improvements is evident.
